Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2017.06.1166
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Low-Dose Rate Brachytherapy for Patients With Low- Or Intermediate-Risk Prostate Cancer: A Systematic Review

Canadian Urological Association Journal
Urology
2013English

Prospective Phase II Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Permanent Prostate Brachytherapy Monotherapy With I-125 for Low- And Intermediate-Risk Prostate Cancer: Outcome in 966 Patients

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2015English

Early Patient-Reported Outcomes in a Randomized Phase II Trial of HDR Monotherapy in Low and Intermediate Risk Prostate Cancer

Brachytherapy
Nuclear MedicineRadiologyImagingOncology
2016English

Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- And Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Focal Low-Dose Rate Brachytherapy for the Treatment of Prostate Cancer

Cancer Management and Research
Oncology
2013English

Successful Subject Recruitment for a Prostate Cancer Behavioral Intervention Trial

Clinical Trials
MedicinePharmacology
2010English

Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2014English

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial

BJU International
Urology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy